Ideas
Mirovα, Creating Sustainable Value - September 2024
Published on 09/20/2024
Monthly market review and outlook
Acting as a responsible investor 2023
Published on 07/24/2024
Sustainability report (Article 29-LEC)
Land Degradation Neutrality Fund (LDN): Impact Report 2023
Published on 07/22/2024
Discover the Land Degradation Neutrality Fund 2023 Impact Report
Trending Forward: Investing Insights from the Sustainable Equity Team
Published on 07/17/2024
The growing market for GLP 1 DRUGSAs obesity rates swell worldwide, popular GLP-1 (Glucagon-like peptide-1) drugs such as Ozempic and Wegovy have generated investor interest. Demand for these drugs has outstripped supply and companies such as Novo Nordisk and Eli Lilly have a strong hold on the market share. Investors should also consider the broader market opportunities and cross-sector implications of GLP-1 drugs.
